lazertinib Breaking News In Brief This Week: Qiagen, Devyser Diagnostics, PathAI, TruDiagnostic Roche Preeclampsia Assay Nabs FDA 510(k) Clearance QuidelOrtho Q4 Revenues Dip 5 Percent, Beat Estimates Grail Stock Surges on Quest Diagnostics Integration of Galleri MCED Test Craig-Hallum Initiates Coverage of Myriad Genetics With a Buy Rating Roche, Abbott, Inflammatix, Paige, Others Gain 510(k) Clearances in January